NFKB1 and Alzheimer disease: Additionally, Aβ oligomers can activate astrocytes in mice possibly through binding directly to C1q (released by microglia), leading to activation of NF-κB and release of C3 complement (increased in AD patients), which are toxic to both microglia and neurons [299, 305, 306].